Sarah Kennedy Calocurb CEO on the company's ambitions to scale its plant based weight-loss product in a market dominated by pharmaceutical giants.

Koreans gripped by the divorce of the century and what it means for SK Hynix - Fri 24 Jul
01:42

The forces shaping Wall Street in 2026 - Fri 24 Jul
04:10

Why AI is driving new investment in New Zealand's power future? - Fri 24 Jul
05:32